Acadia snaps up an essential tremor drug after field’s summer setbacksnews2024-11-27T12:22:20+00:00November 27th, 2024|Endpoints News|
Food allergy biotech Alladapt closes after Phase 3 talks with FDAnews2024-11-26T16:04:03+00:00November 26th, 2024|Endpoints News|
Gilead buys experimental HIV vaccines from a small Barcelona biotechnews2024-11-25T13:41:20+00:00November 25th, 2024|Endpoints News|
ADC biotech Adcendo nabs $135M Series B as it enters the clinicnews2024-11-25T12:00:12+00:00November 25th, 2024|Endpoints News|
Enveda raises $130M for drugs in I&I, obesity and other areasnews2024-11-22T01:46:46+00:00November 22nd, 2024|Endpoints News|
Venrock adds $500M to healthcare investing strategy after outlining 10th fund in Januarynews2024-11-20T21:09:32+00:00November 20th, 2024|Endpoints News|
Carolyn Bertozzi’s new biotech debuts with $30M for immunotherapy worknews2024-11-20T12:00:53+00:00November 20th, 2024|Endpoints News|
Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagshipnews2024-11-20T12:00:40+00:00November 20th, 2024|Endpoints News|
Pfizer partners with two more Flagship biotechs on obesity, cancernews2024-11-20T11:30:45+00:00November 20th, 2024|Endpoints News|
Jupiter Bioventures raises $70M fund for ‘super-early’ sciencenews2024-11-19T13:00:15+00:00November 19th, 2024|Endpoints News|
